Biocon's pre-tax profit rises 9% to Rs 315 crore in Oct-Dec quarter

The consolidated Ebitda margin stood at 27% in Q3FY20.

Biotechnology major Biocon on Thursday posted a profit before tax (PBT) of Rs 315 crore for the third quarter ended December 31, 2019, a muted rise of 9 per cent when compared with the corresponding period of previous financial year.  

The net profit for the period declined 7 per cent to Rs 203 crore on YoY basis though excluding an exceptional item, it saw growth of 6 per cent. Net R&D expenses at Rs 131 crore, which were up by 71 per cent YoY, too, pulled down the profit.

"We witnessed a strong revenue growth of 14 per cent to Rs 1,784